FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to emergency medicine, and may be used for reducing and managing the bronchial asthma status. That is ensured by introducing human urotensin 2 (hU) antiserum that is a hormone of the caudal neurosecretory system (CNSS) one a day intracutaneously into a palmar surface of the arm in 2-3 points in a dose of 0.1- 0.2 ml and 25% magnesium sulphate intravenously in a dose of 5-10 ml twice a day in a combination with intravenous glucocorticosteroids and bronchial spasmolytic inhalations.
EFFECT: method enables relieving the patients from the bronchial asthma status fast and effective due to its simplicity with the lower drug consumption and reduced length of treatment.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VERSION OF THE METHOD FOR PREVENTING AND TREATING INDIVIDUALS SUFFERING FROM ESTROGEN-AND ANDROGEN-DEPENDENT TUMORS | 2014 |
|
RU2597779C2 |
| METHOD OF DIAGNOSING UROTENSIN-2-DEPENDENT STERILITY IN VERTEBRATE ANIMALS AND PEOPLE | 2012 |
|
RU2500341C1 |
| METHOD OF TERMINATION OF ESTRUS IN FEMALES AND ACUTELY MANIFESTED ESTRUS IN MALES OF MAMMALS | 2014 |
|
RU2558921C1 |
| METHOD FOR PREPARING ANTISERUM AGAINST MAMMAL CAUDAL NEUROSECRETORY SYSTEM (CNSS)PEPTIDES | 2003 |
|
RU2272650C2 |
| METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
| METHOD OF TREATING STATUS ASTHMATICUS | 0 |
|
SU1556680A1 |
| METHOD FOR TREATING RELAPSING BRONCHITIS IN CHILDREN | 2006 |
|
RU2303982C1 |
| METHOD FOR PROGNOSTICATION OF HORMONAL THERAPY EFFECTIVENESS IN PATIENTS WITH BRONCHIAL ASTHMA | 0 |
|
SU1651908A1 |
| METHOD OF CHRONIC OBSTRUCTIVE LUNG DISEASE (BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE LUNG DISEASE) MEDICAL TREATMENT | 2006 |
|
RU2326647C2 |
| METHOD OF TREATING MODERATE HOUSE ATOPIC BRONCHIAL ASTHMA IN PATIENTS WITH IMMUNE DEFICIENCY SUFFERING FROM FREQUENT ACUTE RESPIRATORY INFECTIONS | 2013 |
|
RU2533284C1 |
